5//SEC Filing
Holtzman Douglas 5
Accession 0001209191-23-009242
CIK 0001786255other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:15 PM ET
Size
6.1 KB
Accession
0001209191-23-009242
Insider Transaction Report
Form 5
Icosavax, Inc.ICVX
Holtzman Douglas
Chief Scientific Officer
Transactions
- Award
Common Stock
2022-05-31$5.77/sh+1,667$9,619→ 294,925 total
Holdings
- 2,792(indirect: By Stanley Holtzman)
Common Stock
Footnotes (2)
- [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022 by the Reporting person in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).
- [F2]Douglas Holtzman, Ph.D. holds power-of-attorney (POA) over the shares owned by Stanley Holtzman. As POA, Dr. Holtzman holds voting and dispositive control over such shares. Dr. Holtzman disclaims beneficial ownership of the shares over which he has POA except to the extent of any pecuniary interest therein.
Documents
Issuer
Icosavax, Inc.
CIK 0001786255
Entity typeother
Related Parties
1- filerCIK 0001874371
Filing Metadata
- Form type
- 5
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:15 PM ET
- Size
- 6.1 KB